NCT06131541

Brief Summary

The aim of this study is to evaluate the radiographic and the clinical outcomes of application of the alveolar ridge splitting (ARS) in combination with ATG, associated with immediate implant placement versus ARS in combination with autogenous bone graft, associated with immediate implant placement in patients with horizontal bony insufficiency of alveolar ridges.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 9, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 14, 2023

Completed
1 day until next milestone

Study Start

First participant enrolled

November 15, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2024

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2024

Completed
Last Updated

March 20, 2025

Status Verified

March 1, 2025

Enrollment Period

1 year

First QC Date

November 9, 2023

Last Update Submit

March 16, 2025

Conditions

Keywords

Ridge splittingAutogenous Tooth Graftsimultaneous implant placement

Outcome Measures

Primary Outcomes (3)

  • Stability Quotient of Implants (SQI)

    The implant stability was recorded using Osstell TM. Following implant insertion, SQI readings were taken immediately, then again after six and twelve months.

    12-month.

  • Horizontal bone dimensions (HBDs)

    The HBD alterations were assessed by measuring horizontal spacing between the external edges of labial and palatal bony plates at a level 2mm apical of the fixture platform.

    12 months

  • Peri-implant Bone Density (PBD)

    For consistent measurement of the PBD, 1-mm-diameter Region of interest (RI) was selected and traced 1.2 mm distant from the fixture on the cross-sectional slices followed by counting the threshold pixels inside the RI.

    12 months

Secondary Outcomes (1)

  • Pink esthetic score (PES)

    12 months

Study Arms (2)

Group I: autogenous bone graft group

EXPERIMENTAL

11 subjects will be assigned to receive alveolar ridge splitting in combination with autogenous bone graft associated with immediate implant placement

Procedure: autogenous bone graft

Group II: autogenous tooth graft group

EXPERIMENTAL

11 subjects will be assigned to receive alveolar ridge splitting in combination with undemineralized autogenous tooth graft associated with immediate implant placement

Procedure: autogenous tooth graft

Interventions

undemineralized autogenous tooth graft will augment the gap between the splitted ridge and the simultaneously \[laced implant fixture

Group II: autogenous tooth graft group

autogenous bone graft will augment the gap between the splitted ridge and the simultaneously \[laced implant fixture

Group I: autogenous bone graft group

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Good general health at the time of surgery
  • At least 3 months of healing after tooth extraction
  • Horizontally compromised alveolar ridges at least 10 mm high and 3 mm wide.

You may not qualify if:

  • A vertical bone defect in the edentulous ridge;
  • Thick cortex in the labial/buccal with less cancellous bone inside;
  • Obvious undercut on the labial/buccal side;
  • Uncontrolled periodontal conditions or other oral disorders;
  • A history of radiotherapy in the head and neck region

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

faculty of dentistry, kafrelsheikh University

Kafr ash Shaykh, Kafrelsheikh, 214312, Egypt

Location

MeSH Terms

Conditions

Alveolar Bone LossPeri-Implantitis

Condition Hierarchy (Ancestors)

Bone ResorptionBone DiseasesMusculoskeletal DiseasesPeriodontal AtrophyPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Officials

  • WAlid AH Elamrousy, Ph.D

    Kafrelsheikh University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The present clinical trial was single-blinded one as the evaluator and the statistician were both blinded. While both the implantologist or the participant were not blinded as the interventions were dissimilar.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: single-center, prospective, single-blinded, randomized parallel two-arm controlled clinical trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of periodontology

Study Record Dates

First Submitted

November 9, 2023

First Posted

November 14, 2023

Study Start

November 15, 2023

Primary Completion

November 30, 2024

Study Completion

December 15, 2024

Last Updated

March 20, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations